Published in Exp Clin Transplant on December 01, 2009
Renal transplantation in allografts with multiple versus single renal arteries. Saudi J Kidney Dis Transpl (2012) 2.47
Estimation of glomerular filtration rate with creatinine-based versus cystatin C-based equations in kidney transplant recipients. Iran J Kidney Dis (2009) 2.09
Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proc Natl Acad Sci U S A (2007) 1.87
The influence of sodium ion binding on factor IXa activity. Thromb Haemost (2006) 1.47
Prevalence and risk factors of recurrent cytomegalovirus infection in kidney transplant recipients. Iran J Kidney Dis (2014) 1.45
Correlation between the degree of air trapping in chest HRCT and cardiopulmonary exercise test parameters: could HRCT be a predictor of disease severity? Arch Iran Med (2011) 1.42
Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb Haemost (2008) 1.35
Engineering a disulfide bond to stabilize the calcium-binding loop of activated protein C eliminates its anticoagulant but not its protective signaling properties. J Biol Chem (2007) 1.34
Contribution of basic residues of the 70-80-loop to heparin binding and anticoagulant function of activated protein C. Biochemistry (2002) 1.22
Activated protein C inhibits high mobility group box 1 signaling in endothelial cells. Blood (2011) 1.22
Role of basic residues of the autolysis loop in the catalytic function of factor Xa. Biochemistry (2002) 1.22
Ixolaris: a factor Xa heparin-binding exosite inhibitor. Biochem J (2005) 1.14
Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa. Protein Sci (2004) 1.12
Recombinant human activated protein C inhibits integrin-mediated neutrophil migration. Blood (2009) 1.11
Proexosite-1 on prothrombin is a factor Va-dependent recognition site for the prothrombinase complex. J Biol Chem (2003) 1.09
Factor X/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via endothelial protein C receptor-dependent recruitment of PAR-1. J Biol Chem (2010) 1.07
Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin. J Biol Chem (2007) 1.06
Exosite-dependent regulation of factor VIIIa by activated protein C. Blood (2003) 1.04
Identification of a specific exosite on activated protein C for interaction with protease-activated receptor 1. J Biol Chem (2007) 1.04
Localization of the heparin binding exosite of factor IXa. J Biol Chem (2002) 1.04
Thrombin inhibits nuclear factor kappaB and RhoA pathways in cytokine-stimulated vascular endothelial cells when EPCR is occupied by protein C. Thromb Haemost (2009) 1.02
Localization of phosphatidylserine binding sites to structural domains of factor Xa. J Biol Chem (2001) 1.02
Suppression of interleukin-6 by minocycline in a rat model of neuropathic pain. Eur J Pharmacol (2006) 1.00
Concentration dependent dual effect of thrombin in endothelial cells via Par-1 and Pi3 Kinase. J Cell Physiol (2009) 0.98
FRET studies with factor X mutants provide insight into the topography of the membrane-bound factor X/Xa. Biochem J (2007) 0.97
Contribution of basic residues of the autolysis loop to the substrate and inhibitor specificity of factor IXa. J Biol Chem (2003) 0.97
Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor. Biochemistry (2009) 0.96
Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite. Protein Sci (2007) 0.95
Activation of protein C by the thrombin-thrombomodulin complex: cooperative roles of Arg-35 of thrombin and Arg-67 of protein C. Proc Natl Acad Sci U S A (2006) 0.94
The conformation of the activation peptide of protein C is influenced by Ca2+ and Na+ binding. J Biol Chem (2004) 0.93
Calcium-binding sites of the thrombin-thrombomodulin-protein C complex: possible implications for the effect of platelet factor 4 on the activation of vitamin K-dependent coagulation factors. Thromb Haemost (2007) 0.93
Engineering functional antithrombin exosites in alpha1-proteinase inhibitor that specifically promote the inhibition of factor Xa and factor IXa. J Biol Chem (2008) 0.93
Heparin-activated antithrombin interacts with the autolysis loop of target coagulation proteases. Blood (2004) 0.92
Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor. J Biol Chem (2011) 0.92
Spinal mu-opioid receptor expression and hyperalgesia with dexamethasone in chronic adjuvant-induced arthritis in rats. Clin Exp Pharmacol Physiol (2008) 0.90
Identification of a basic region on tissue factor that interacts with the first epidermal growth factor-like domain of factor X. Biochemistry (2007) 0.90
The fourth epidermal growth factor-like domain of thrombomodulin interacts with the basic exosite of protein C. J Biol Chem (2003) 0.90
Role of the N-terminal epidermal growth factor-like domain of factor X/Xa. J Biol Chem (2004) 0.90
Mutations of the anti-mullerian hormone gene in patients with persistent mullerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model. Mol Endocrinol (2003) 0.87
Characterization of the heparin-binding site of the protein z-dependent protease inhibitor. Biochemistry (2012) 0.87
Mechanisms of interactions of factor X and factor Xa with the acidic region in the factor VIII A1 domain. J Biol Chem (2004) 0.86
Thrombomodulin enhances the reactivity of thrombin with protein C inhibitor by providing both a binding site for the serpin and allosterically modulating the activity of thrombin. J Biol Chem (2003) 0.86
Psoriasis and increased prevalence of hypertension and diabetes mellitus. Indian J Dermatol (2011) 0.86
Determinants of the specificity of protease-activated receptors 1 and 2 signaling by factor Xa and thrombin. J Cell Biochem (2012) 0.86
Thrombin inhibits HMGB1-mediated proinflammatory signaling responses when endothelial protein C receptor is occupied by its natural ligand. BMB Rep (2013) 0.85
Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase. Thromb Haemost (2012) 0.85
Membrane-dependent interaction of factor Xa and prothrombin with factor Va in the prothrombinase complex. Biochemistry (2009) 0.85
The cofactor function of the N-terminal domain of tissue factor. J Biol Chem (2004) 0.85
Phosphatidylserine-induced factor Xa dimerization and binding to factor Va are competing processes in solution. Biochemistry (2012) 0.85
Opioid receptor antagonist promotes angiogenesis in bile duct ligated rats. J Gastroenterol Hepatol (2009) 0.85
Expression, purification and characterization of factor IX derivatives using a novel vector system. Protein Expr Purif (2006) 0.84
Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa. Thromb Haemost (2009) 0.83
Variation in plasma leptin levels in young Iranian children with cystic fibrosis. Arch Med Sci (2013) 0.82
Adenosine regulates the proinflammatory signaling function of thrombin in endothelial cells. J Cell Physiol (2014) 0.82
Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa. J Biol Chem (2010) 0.81
Functional mapping of charged residues of the 82-116 sequence in factor Xa: evidence that lysine 96 is a factor Va independent recognition site for prothrombin in the prothrombinase complex. Biochemistry (2005) 0.81
Identification of exosite residues of factor Xa involved in recognition of PAR-2 on endothelial cells. Biochemistry (2012) 0.81
Thrombin down-regulates the TGF-beta-mediated synthesis of collagen and fibronectin by human proximal tubule epithelial cells through the EPCR-dependent activation of PAR-1. J Cell Physiol (2010) 0.81
Mutagenesis studies toward understanding allostery in thrombin. Biochemistry (2009) 0.81
Incidence and risk factors of transplant renal artery stenosis in living unrelated donor renal transplantation. J Ren Care (2010) 0.81
The missense Thr211Pro mutation in the factor X activation peptide of a bleeding patient causes molecular defect in the clotting cascade. Thromb Haemost (2013) 0.81
Cutaneous leiomyoma: novel histologic findings for classification and diagnosis. Acta Med Iran (2013) 0.79
Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa. J Biol Chem (2013) 0.79
Thrombin and activated protein C inhibit the expression of secretory group IIA phospholipase A(2) in the TNF-alpha-activated endothelial cells by EPCR and PAR-1 dependent mechanisms. Thromb Res (2009) 0.79
The functional significance of the autolysis loop in protein C and activated protein C. Thromb Haemost (2005) 0.79
Protective effect of hydroalcoholic olive leaf extract on experimental model of colitis in rat: involvement of nitrergic and opioidergic systems. Phytother Res (2014) 0.79
Obesity and urologic complications after renal transplantation. Saudi J Kidney Dis Transpl (2014) 0.78
Promoter region polymorphisms in the transforming growth factor beta-1 (TGFβ1) gene and serum TGFβ1 concentration in preeclamptic and control Iranian women. J Reprod Immunol (2012) 0.78
Effect of low-level laser therapy on skin fibroblasts of streptozotocin-diabetic rats. Photomed Laser Surg (2007) 0.78
Activated protein C protects against renal ischaemia/reperfusion injury, independent of its anticoagulant properties. Thromb Haemost (2016) 0.78
Factor Va alters the conformation of the Na+-binding loop of factor Xa in the prothrombinase complex. Biochemistry (2008) 0.77
Autolysis loop restricts the specificity of activated protein C: analysis by FRET and functional assays. Biophys Chem (2008) 0.77
Functional properties and active-site topographies of factor X Gla- and prothrombin Gla-domain chimeras of activated protein C. Biochim Biophys Acta (2008) 0.77
Thrombomodulin-mediated catabolism of protein C by pleural mesothelial and vascular endothelial cells. Thromb Haemost (2007) 0.77
Impact of obesity on urologic complications among unrelated living donor kidney transplants. Indian J Surg (2010) 0.76
Proexosite-1-dependent recognition and activation of prothrombin by taipan venom. J Biol Chem (2004) 0.76
The cardioprotective effects of an antiemetic drug, tropisetron, on cardiomyopathy related to doxorubicin. Cardiovasc Toxicol (2012) 0.76
Role of P2 glycine in determining the specificity of antithrombin reaction with coagulation proteases. Biochem Biophys Res Commun (2009) 0.75
Mutation of the H-helix in antithrombin decreases heparin stimulation of protease inhibition. Biochim Biophys Acta (2007) 0.75
Contributory role of viral infection in congenital tumour development. Ecancermedicalscience (2013) 0.75
Thrombomodulin modulates cell migration in human melanoma cell lines. Melanoma Res (2014) 0.75
Plasma ghrelin levels in children with cystic fibrosis and healthy children. Arch Med Sci (2012) 0.75
Inhibitory properties of the P1 Tyr variant of antithrombin. Biochemistry (2010) 0.75
Variable contributions of basic residues forming an APC exosite in the binding and inactivation of factor VIIIa. Biochemistry (2013) 0.75
Is There any Association Between Passive Smoking and Esophagitis in Pediatrics? Iran J Pediatr (2013) 0.75
Evaluation of QT Interval in β Thalassemia Major Patients in Comparison with Control Group. Heart Views (2012) 0.75
Prevalence of different electrocardiographic patterns in Iranian athletes. Acta Med Iran (2012) 0.75
Acute Interstitial Nephritis Induced by Citrullus Colocynthis. Iran J Kidney Dis (2017) 0.75
Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II. Thromb Res (2002) 0.75
Transmitting the allosteric signal in methylglyoxal synthase. Protein Eng Des Sel (2013) 0.75
Correction to Phosphatidylserine-Induced Factor Xa Dimerization and Binding to Factor Va Are Competing Processes in Solution. Biochemistry (2016) 0.75